Bahl & Gaynor Inc Zoetis Inc. Transaction History

Bahl & Gaynor Inc

$17.9 Billion
Q2 2024

A detailed history of Bahl & Gaynor Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 147,904 shares of ZTS stock, worth $28.9 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

147,904

Previous 30,177 390.12%

Holding current value

$28.9 Million

Previous $5.11 Million 402.15%

% of portfolio

0.14%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$145.54 - $178.83 $17.1 Million - $21.1 Million	117,727 Added 390.12%	147,904 $25.6 Million
Q1 2024 May 10, 2024	SELL	$165.67 - $199.94 $360,829 - $435,469	-2,178 Reduced 6.73%	30,177 $5.11 Million
Q4 2023 Feb 02, 2024	SELL	$151.44 - $200.09 $72,236 - $95,442	-477 Reduced 1.45%	32,355 $6.39 Million
Q3 2023 Nov 03, 2023	SELL	$167.14 - $192.77 $129,032 - $148,818	-772 Reduced 2.3%	32,832 $5.71 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $507,604 - $587,369	-3,154 Reduced 8.58%	33,604 $5.79 Million
Q1 2023 May 03, 2023	SELL	$145.48 - $175.02 $825,599 - $993,238	-5,675 Reduced 13.37%	36,758 $6.12 Million
Q4 2022 Feb 10, 2023	SELL	$131.14 - $157.47 $664,224 - $797,585	-5,065 Reduced 10.66%	42,433 $6.22 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $267,218 - $328,955	-1,802 Reduced 3.66%	47,498 $7.04 Million
Q2 2022 Aug 08, 2022	BUY	$155.97 - $200.09 $585,511 - $751,137	3,754 Added 8.24%	49,300 $8.47 Million
Q1 2022 May 12, 2022	BUY	$181.39 - $234.03 $838,203 - $1.08 Million	4,621 Added 11.29%	45,546 $8.59 Million
Q4 2021 Feb 10, 2022	BUY	$193.69 - $247.03 $818,340 - $1.04 Million	4,225 Added 11.51%	40,925 $9.99 Million
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $60,951 - $67,520	322 Added 0.89%	36,700 $7.13 Million
Q2 2021 Aug 06, 2021	SELL	$155.9 - $187.99 $114,586 - $138,172	-735 Reduced 1.98%	36,378 $6.78 Million
Q1 2021 May 11, 2021	SELL	$144.0 - $169.39 $592,416 - $696,870	-4,114 Reduced 9.98%	37,113 $5.84 Million
Q4 2020 Feb 02, 2021	BUY	$157.07 - $174.35 $78,220 - $86,826	498 Added 1.22%	41,227 $6.82 Million
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $99,808 - $120,389	728 Added 1.82%	40,729 $6.74 Million
Q1 2020 May 26, 2020	BUY	$92.66 - $144.94 $3.71 Million - $5.8 Million	40,001 New	40,001 $4.71 Million
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $3.71 Million - $5.8 Million	-40,001 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $5,231 - $5,996	45 Added 0.11%	40,001 $5.29 Million
Q3 2019 Nov 14, 2019	BUY	$112.57 - $128.43 $65,515 - $74,746	582 Added 1.48%	39,956 $4.98 Million
Q2 2019 Aug 12, 2019	BUY	$97.98 - $114.28 $1.92 Million - $2.24 Million	19,619 Added 99.31%	39,374 $4.47 Million
Q1 2019 May 13, 2019	SELL	$81.56 - $100.67 $91,347 - $112,750	-1,120 Reduced 5.37%	19,755 $1.99 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $1.66 Million - $1.86 Million	-20,801 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$71.51 - $84.69 $10,726 - $12,703	-150 Reduced 0.72%	20,801 $1.74 Million
Q4 2017 Feb 13, 2018	BUY	$63.24 - $72.8 $9,486 - $10,920	150 Added 0.72%	20,951 $1.51 Million
Q2 2017 Aug 11, 2017	SELL	N/A	-903 Reduced 4.16%	20,801 $1.3 Million
Q2 2017 Aug 10, 2017	BUY	N/A	21,704	21,704 $1.16 Million

Others Institutions Holding ZTS

# of Institutions

1,897

Shares Held

423M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $91.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account